Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Feb 10, 2026
Eastgate Biotech Market Cap
Eastgate Biotech has a market cap or net worth of $105.79 thousand as of February 13, 2026. Its market cap has decreased by -97.50% in one year.
Market Cap
105.79K
Enterprise Value
n/a
Revenue
137.64K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 5, 2014, Eastgate Biotech's market cap has decreased from 7.91M to 105.79K, a decrease of -98.66%. That is a compound annual growth rate of -30.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 105.79K | -96.67% |
| Dec 18, 2025 | 3.17M | -33.33% |
| Dec 23, 2024 | 4.76M | 50.00% |
| Dec 30, 2022 | 3.17M | 11.11% |
| Dec 31, 2021 | 2.86M | -32.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regen BioPharma | 206.31K |
| Endonovo Therapeutics | 180.76K |
| GB Sciences | 153.72K |
| Synairgen | 110.27K |
| Nascent Biotech | 86.42K |
| Itoco | 85.64K |
| Vincerx Pharma | 66.74K |
| Affymax | 59.59K |